Literature DB >> 15109551

Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon.

Helen K Kimbi1, Kevin K A Tetteh, Spencer D Polley, David J Conway.   

Abstract

To investigate relationships between Plasmodium falciparum parasitaemia, parasite genotypes, and specific anti-parasite antibodies, 244 school children (aged 4 to 16 years) were studied in April/May 2002, the peak malaria transmission season in Buea, Cameroon. Antibody reactivities were analysed by ELISA using an array of recombinant antigens representing different sequences from the polymorphic block 2 region of the merozoite surface protein 1 (MSP1), and the blood samples that were slide-positive for P. falciparum were genotyped for msp1 block 2 alleles. The prevalence of antibodies to the specific MSP1 block 2 antigens was significantly higher in children at one particular school (situated at the lowest altitude) compared to the others, although the prevalence of infection or particular parasite genotypes did not differ. Thus, at a population level, the prevalence of these antibodies does not simply reflect prevalence of parasites, but rather may be due to differences in the incidence of past infections. However, there were weak positive associations between specific antibody reactivity and the presence of the corresponding allele in the blood of individuals (statistically significant for the MAD20-type allele of block 2), indicating that antibody specificities are to some extent determined by current parasite infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109551     DOI: 10.1016/S0035-9203(03)00068-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes.

Authors:  John P A Lusingu; Anja T R Jensen; Lasse S Vestergaard; Daniel T Minja; Michael B Dalgaard; Samwel Gesase; Bruno P Mmbando; Andrew Y Kitua; Martha M Lemnge; David Cavanagh; Lars Hviid; Thor G Theander
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

3.  Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates.

Authors:  Anna M Leitgeb; Karin Blomqvist; Fidelis Cho-Ngwa; Moses Samje; Peter Nde; Vincent Titanji; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

4.  Genetic diversity of Plasmodium falciparum merozoite surface protein-1 block 2 in sites of contrasting altitudes and malaria endemicities in the Mount Cameroon region.

Authors:  Samuel Wanji; Arnaud J Kengne-Ouafo; Ebanga E Joan Eyong; Helen K Kimbi; Nicholas Tendongfor; Judith L Ndamukong-Nyanga; Hugues C Nana-Djeunga; Catherine Bourguinat; David D Sofeu-Feugaing; Claude L Charvet
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

5.  A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1.

Authors:  Kevin K A Tetteh; David J Conway
Journal:  Vaccine       Date:  2011-08-04       Impact factor: 3.641

6.  KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.

Authors:  Gathoni Kamuyu; James Tuju; Rinter Kimathi; Kennedy Mwai; James Mburu; Nelson Kibinge; Marisa Chong Kwan; Sam Hawkings; Reuben Yaa; Emily Chepsat; James M Njunge; Timothy Chege; Fatuma Guleid; Micha Rosenkranz; Christopher K Kariuki; Roland Frank; Samson M Kinyanjui; Linda M Murungi; Philip Bejon; Anna Färnert; Kevin K A Tetteh; James G Beeson; David J Conway; Kevin Marsh; Julian C Rayner; Faith H A Osier
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

7.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

8.  Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.

Authors:  F H A Osier; S D Polley; T Mwangi; B Lowe; D J Conway; K Marsh
Journal:  Parasite Immunol       Date:  2007-08       Impact factor: 2.280

9.  Plasmodium falciparum merozoite surface protein 1 block 2 gene polymorphism in field isolates along the slope of mount Cameroon: a cross - sectional study.

Authors:  Tobias O Apinjoh; Rolland B Tata; Judith K Anchang-Kimbi; Hanesh F Chi; Eleanor M Fon; Regina N Mugri; Delphine A Tangoh; Robert V Nyingchu; Stephen M Ghogomu; Theresa Nkuo-Akenji; Eric A Achidi
Journal:  BMC Infect Dis       Date:  2015-08-05       Impact factor: 3.090

10.  An expanded global inventory of allelic variation in the most extremely polymorphic region of Plasmodium falciparum merozoite surface protein 1 provided by short read sequence data.

Authors:  Harvey Aspeling-Jones; David J Conway
Journal:  Malar J       Date:  2018-10-01       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.